Implantica Investor Relations Material
Latest events
Q1 2025
Implantica
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Implantica
Access all reports
Implantica AG with headquarters in Horw/Luzern (Switzerland) is a company developing and distributing innovative solutions for reconstructive surgery. The company’s range of products includes implants based on the unique Zoladex® technology, which is used in a wide variety of applications such as industrial implants, biodegradable drug carriers and scaffolds. In addition Implantica provides best-in-class synthetic meshes for use in hernia repair procedures.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
IMP
Country
🇸🇪 Sweden